Mounjaro medication: what you're actually taking and why it works differently

You've heard about this medication, here's what's actually in the pen

Imagine you've just read about Mounjaro for the third time this week. Maybe a friend mentioned it, or you saw it referenced in a news article alongside the word "tirzepatide". The question most people arrive with is simple: what medication is tirzepatide, really?

Tirzepatide is a synthetic peptide that mimics two naturally occurring gut hormones: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). When you eat, your gut releases both to signal fullness, slow digestion and regulate blood sugar. Tirzepatide activates both receptor pathways at once. That dual action is what separates Mounjaro from earlier GLP-1-only medicines, it influences appetite through two complementary signals rather than one.

Each Mounjaro KwikPen contains four weekly doses of a single strength. The pen is pre-filled and pre-set; you inject once a week into your abdomen, thigh or upper arm, rotating the site each time. Strengths available in the UK run from 2.5 mg through to 15 mg in six steps. You can read more about the injection itself on our Mounjaro injection guide.

The NHS medicines page for tirzepatide covers the full patient-level detail, including how the medicine works in the body and what to watch for, worth a read alongside whatever your prescriber tells you.

What the trial data actually showed

SURMOUNT-1 is the headline study. It randomised 2,539 adults with obesity or overweight plus at least one weight-related condition, following them for 72 weeks. On the highest dose, 15 mg, participants lost an average of around 20–21% of starting body weight. To put that in context, earlier single-receptor GLP-1 medicines produced average losses closer to 15%. The trial was published in the New England Journal of Medicine and formed the clinical basis for NICE's appraisal of tirzepatide, TA1026, published in December 2024.

Those are group averages, not personal predictions. Individual results varied, some participants lost considerably more, others less. Weight, dose tolerance, diet, activity and underlying health all play a role. No medication produces identical results across different people, and results described in trials reflect supervised conditions with structured lifestyle support running alongside treatment.

NICE recommends tirzepatide for adults with a BMI of 35 or above plus at least one weight-related comorbidity such as high blood pressure, type 2 diabetes or obstructive sleep apnoea, with lower BMI thresholds applying for some ethnic backgrounds under UK guidance. Private prescribing criteria differ slightly (the licensed threshold is a BMI of 30 or above, or 27 with a qualifying condition) and a prescriber weighs the full clinical picture, not BMI alone.

If you're curious how the cost of treatment sits alongside this evidence, our Mounjaro cost page sets out what private treatment realistically involves in the UK.

Side effects: what most people notice, and what needs urgent attention

The most commonly reported effects are gastrointestinal. Nausea tends to be the one people mention first. It often surfaces in the early weeks or after a dose increase, then settles as the body adjusts. Constipation, diarrhoea, indigestion and a general sense of fullness are also frequently reported. Fatigue and mild headache appear in some people, particularly at the start.

Most of these are manageable. Eating smaller portions, staying well hydrated and avoiding very fatty meals can reduce the impact. The 2.5 mg starting dose exists specifically to give your system time to adapt before the dose increases.

A smaller number of people experience effects that need prompt medical attention. Severe, persistent stomach pain that radiates through to the back (with or without vomiting) can be a sign of pancreatitis, which the MHRA highlighted as a known but infrequent serious risk in a Drug Safety Update in January 2026. Other signs warranting urgent review include symptoms suggesting gallbladder problems, signs of dehydration from prolonged vomiting or diarrhoea, or any allergic reaction. If you are on oral contraceptives, your prescriber will advise adding a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because tirzepatide slows gastric emptying in a way that can affect pill absorption.

You can explore the broader Mounjaro overview for a fuller picture of the medicine, or speak to our prescribers if you have specific questions about a health condition you're managing alongside treatment.

How this medication is prescribed and what accessing it actually involves

Mounjaro is a prescription-only medicine. There is no legal route to it in the UK that bypasses a clinical assessment. On the NHS, access is phased and criteria are strict, most people currently need a BMI of 40 or above alongside multiple qualifying conditions to qualify, and availability varies by area. Many people who are eligible in principle face a wait.

Private prescribing through a regulated online pharmacy is the other route. At nume, a GPhC-registered Independent Prescriber personally reviews every consultation, not software, not a triage algorithm. If approved, treatment is dispatched the same day for orders placed before midday, and arrives via DPD the next working day in plain, unbranded packaging. The tracking notification lands on your phone before the driver does. That's the practical reality of how it works.

To understand whether you're clinically suitable, the only meaningful step is a consultation. If you also take other prescribed medicines and want to understand how they interact with this treatment, our page on Mounjaro and ADHD medication is a useful starting point for one of the more common questions we receive. Our weight-loss medication page for Mounjaro explains what the assessment covers, including what type of medication Mounjaro is and how that shapes the prescribing decision, or you can go straight to start your free consultation and a prescriber will review your answers the same day.